Alembic releases generic Arranon
Nelarabine injection is indicated for the treatment of T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma.
Alembic is introducing nelarabine injection, 250mg/50ml (5mg/ml) single-dose vial, which is the generic of Sandoz’s Arranon.
Nelarabine Injection is a nucleoside metabolic inhibitor indicated for the treatment of patients with T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma in adult and pediatric patients aged 1 year and older whose disease has responded to or has relapsed following treatment with at least two chemotherapy regimens.
[Read more: Alembic intros generic Perforomist]
Alembic’s nelarabine injection is available in 250mg/50ml (5mg/ml in a single unit of 250mg/50mL single-dose vials and cartons of six units of 250mg/50mL Single-Dose vials.
[Read more: Alembic releases generic Pradaxa]